Intravenous foscarnet administration for treatment of cytomegalovirus retinitis.

Abstract	Cytomegalovirus (CMV) causes serious infections, particularly vision-threatening retinitis, in persons with acquired immune deficiency syndrome. Foscarnet has been demonstrated to delay the progression of CMV retinitis and is an alternative to ganciclovir. Adverse reactions to foscarnet include nephrotoxicity and hypocalcemia and can impact the patient's ability to tolerate treatment. Nursing implications and interventions essential in helping the patient achieve an optimal outcome also are presented.
Authors	J G Greening
Journal	Journal of intravenous nursing : the official publication of the Intravenous Nurses Society (J Intraven Nurs) 1994 Mar-Apr Vol. 17 Issue 2 Pg. 74-7 ISSN: 0896-5846 [Print] United States
PMID	8064492 (Publication Type: Journal Article)
Chemical References	Foscarnet
Topics	AIDS-Related Opportunistic Infections (drug therapy, nursing) Cytomegalovirus Retinitis (drug therapy, nursing) Foscarnet (therapeutic use) Humans Infusions, Intravenous Patient Care Planning

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!